US Edition
Blood test for early signs of pancreatic cancer trialled by UK doctors
- A new blood test is being trialled in the UK to detect early signs of pancreatic cancer, which is often difficult to diagnose due to vague symptoms.
- The Avantect test is 68 percent accurate in identifying early-stage pancreatic cancer and 97 percent accurate in ruling out healthy individuals.
- This trial focuses on patients with recent diagnoses of type 2 diabetes, a recognized risk factor for pancreatic cancer.
- Researchers emphasize the importance of early detection for improving treatment options and long-term survival rates.
Insights by Ground AI
Does this summary seem wrong?
12 Articles
12 Articles
All
Left
3
Center
3
Right
1
The Independent+2 Reposted by 2 other sources
‘Promising’ new test could detect pancreatic cancer in its early stages
Pancreatic cancer kills almost 10,000 people in the UK every year
·London, United Kingdom
Read Full Article
ClearNote Health initiates study of test to detect early pancreatic cancer
ClearNote Health has commenced subject enrolment in a multicentre, prospective study involving its Avantect pancreatic cancer test.The post ClearNote Health initiates study of test to detect early pancreatic cancer appeared first on Medical Device Network.
Coverage Details
Total News Sources12
Leaning Left3Leaning Right1Center3Last UpdatedBias Distribution43% Left, 43% Center
Bias Distribution
- 43% of the sources lean Left, 43% of the sources are Center
43% Center
L 43%
C 43%
14%
Factuality
To view factuality data please Upgrade to Premium
